Feedback / Questions
DPX-101 - Damona Pharmaceuticals
https://www.prnewswire.com/news-releases/damona-announces-publication-of-preclinical-proof-of-concept-data-for-dpx-101-gl-ii-73-demonstrating-symptomatic-and-disease-modifying-potential-for-the-treatment-of-cognitive-deficits-in-alzheimers-disease-302367081.html
Feb 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next